Prion propagation in mice lacking central nervous system NF-kappaB signalling

Area of Science:

• Neuroscience
• Molecular Biology
• Pathology

Background:

• Prions cause neurodegeneration through unknown molecular pathways.
• Enhanced nuclear factor-kappaB (NF-kappaB) activity is observed early in prion infection.
• NF-kappaB signaling regulates crucial cellular processes like apoptosis and inflammation.

Purpose of the Study:

• To investigate the role of NF-kappaB signaling in prion pathogenesis.
• To determine if inhibiting NF-kappaB signaling in the central nervous system (CNS) affects prion disease development.

Main Methods:

• Utilized mouse models with CNS-restricted elimination of IKKbeta or IKKgamma.
• Employed mice with a non-phosphorylatable IKKalpha subunit (IKKalpha AA/AA).
• Examined the impact of impaired NF-kappaB signaling on prion disease pathology.

Main Results:

• No evidence was found supporting the hypothesis that impaired NF-kappaB signaling impacts prion pathogenesis.
• Contrary to previous data, CNS-specific NF-kappaB inhibition did not alter disease course.
• Prion disease progression was unaffected by genetic modifications of the NF-kappaB pathway.

Conclusions:

• NF-kappaB signaling in the CNS is not a critical determinant of prion disease pathogenesis.
• The molecular pathways driving prion-induced neurodegeneration remain to be fully elucidated.
• Further research is needed to identify key molecular targets in prion disease treatment.